Comparison of model predictions of typhoid conjugate vaccine public health impact and cost-effectiveness

Cost-effectiveness and public health impact of typhoid conjugate vaccine introduction strategies in Bangladesh

“…For example, in the status quo analysis, we projected that children and Dhaka will be disproportionately affected. Our findings were also broadly consistent with past studies that have projected that typhoid conjugate vaccination can be cost effective and even cost saving in typhoid endemic areas [19] , [21] , [41] , [42] , [43] , [44] . A major constraint for past country-level cost-effectiveness analyses has been a paucity of incidence data, particularly outside of selected urban settings where typhoid surveillance studies have been conducted.…”